Johnson & Johnson settles nationwide for $700 million over claims of misleading talcum powder safety marketing

Johnson & Johnson has agreed to a $700 million settlement to resolve claims nationwide alleging misleading marketing of talcum-based powders. This settlement, subject to court approval, mandates the company to cease manufacturing and selling talc-containing products like Johnson's Baby Powder. The agreement includes payments to 42 states and Washington, D.C. J&J, facing over 50,000 claims primarily from women linking talc to cancer, continues to negotiate a broader resolution. Recent jury awards highlight ongoing legal challenges, including substantial payouts to plaintiffs. The company previously offered $6.5 billion to settle all talc-related lawsuits amid mounting legal and public scrutiny.